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who was on peritoneal dialysis, all other patients were on
regular hemodialysis. five patients were referred to car-
diac surgery as their coronary artery disease was
detected during routine coronary angiography before
renal transplant.
Results: There was one postoperative death (in-hos-
pital mortality, 6.6%). The patient who died was suffering
from morbid obesity with severe LV dysfunction and
poor target coronary artery vessels. Three patients
underwent renal transplantation after CABG operation
and another one patient was recently operated and is
waiting for transplant. One patient was complicated with
significant perioperative MI after having LAD endartrec-
tomy and surgical reconstruction with LIMA; this was
complicated with heart failure and moderate to severe
MR. This patient had lost his chance for future renal
transplant. One patient had cerebral hemorrhage 2
months after surgery and he recovered.
Conclusions: Cardiac operations in patients with
end-stage renal disease may be performed with a fairly
low perioperative risk and the perspective of short-term
functional improvement and acceptable survival. How-
ever, careful selection is mandatory for better outcome.
http://dx.doi:10.1016/j.jsha.2013.03.041
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Introduction: We report the first national Scottish
experience with ventricularassist- devices (VADs) in a
selected group of patients for whom short-term VADs
(ST-VADs) were used as a salvage ‘bridge-to-decision’
(BTD) and long-term VADs (LT-VADs) as a ‘bridge-to-
transplantation/recovery’ (BTT/BTR). Method: From Jan-
uary 2010–July 2012, 13 (mean-age 42.4(16–62) years)
INTERMACS I patients required emergency ST-VAD
support as BTD and 9 (meanage 35.4(16-53) years)
INTERMACS I–IV required LT-VADs as BTT/BTR.
Results: Of BTD patients, 8(61.5%) received ST-BiV-
ADs, 3(23.1%) ST-LVADs and 2(15.4%) peripheral Centr-
iMag ECMO. Nine(69.2%) survived to last follow-up:
1(7.7%) is on ST-VAD support, 5(45.5%) bridged to myo-
cardial-recovery and VADexplantation, 1(9.1%) to trans-
plantation and 2(9.1%) to LT-support. Mean durations
of ST-support, renal-support and postoperative ICU-stay
were 31.3(2–110), 6.6(0–31) and 35.5(1–119) days, respec-
tively. Four(36.4%) early deaths and one after discharge.
One(7.7%) stroke, 2(15.4%) acute-limb-ischemia and
6(46.2%) re-explored. No driveline-infections or device-
failures. Cumulative survival was 57.1% at 4, 12 and 24
months postoperatively. Of LT-LVAD patients, 6(66.7%)
remain on LT-support, 1(11.1%) bridged to myocardial-
recovery and VAD-explantation, and another to trans-
plantation. Mean postoperative ICU-stay and LT-support
were 19.9(6–56) and 251.3(21–751) days, respectively.
One(1.11%) patient demised after 98 days of support,
2(22.2%) suffered LVAD-induced RV failure, 2(22.2%)
required re-exploration for bleeding and only
one(11.1%) minor superficial driveline-infection was
encountered but no device/pump failure, infection or
thrombosis. Cumulative survival was 85.7% at 4, 12 and
24 months of support.
Conclusion: With undue vigilance, complex VAD-
therapy can be integrated safely into a national program,
treating the most deranged advanced-heart-failure
patients, with low rates of complications and high rates
of myocardial-recovery.
http://dx.doi:10.1016/j.jsha.2013.03.043
Outcomes of acute myocardial infarction in type 2
diabetic yemeni patients using different methods
of treament
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Diabetes (DM) mellitus is a chronic disease that
requires continuing medical care and patient self-man-
agement education to prevent acute complications and
to reduce the risk of long-term complications. Patient
with type 2 DM have a two to fourfold increase incidence
of disease related to atheroma.
Design and methodology: Our study is a single-
centre hospital based cohort prospective (interventional)
study.
All of the studied patients were subjected to history,
clinical evaluation,biochemical investigation. ECG and
Echocardiography were done for them. Interventional
procedures were done for all of the patients such as
PCI or CABG. Statistical analysis was done by SPSS sys-
tem. A total of 150 consecutive Yemeni patients were
included in this study. One hundred (100) patients were
diabetic and fifty (50) patients were control (non dia-
betic). The diabetic patients were treated by different
methods of insulin treatment protocol, 50 patients were
treated by insulin infusion therapy (IIT) and 50 patients
were treated by sliding scale insulin (SSI) protocol.
Anti-ischemic treatment (medications) was given to all
the cases and control groups.
Setting of the work: We recruited all patients
admitted to the intensive care units (cardiac and noncar-
diac)at Al-Thawra Teaching Hospital in Sana’a over 12
months (Jan 2007–Dec 2010).
Objectives of the study: Evaluation of the impact of
IV continuous insulin infusion technique on the outcome
of acute MI as compared to the sliding scale in diabetic
patients. Post MI surveillance of patients was also con-
ducted over the next.
Results: Male predominance was evident in this
study. Mean (±SD) Waist circumference (WC) was signif-
icantly higher in diabetic patients (95.4 ± 15.2 cm) than in
the control (90 ± 13.3 cm) (p = 0.032). Abdominal adiposity
measured as, waist to height ratio (WHtR) was found to
be more prevalent among diabetic patients (70%)
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